Back to News
Market Impact: 0.15
QGEN Crosses Above Average Analyst Target
Source: Nasdaq
Analyst InsightsMarket Technicals & Flows
Qiagen NV shares traded at $45.79, above the average analyst 12-month target of $45.40. The article notes analysts may respond when a stock reaches its target, but provides no specific analyst action or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
QGEN0.10
More News
- US stock market hits all-time high as investors bet big on AI
- Singapore's Temasek warns of the ‘biggest risk’ facing markets right now
- Nvidia Is on the Verge of a $6 Trillion Market Value
- JPMorgan and Deutsche Bank just upgraded Brazilian stocks. How to trade them
- What Marvell's rosy long-term guidance means for our AI chip stocks
- GIC Private Ltd, Medline 10% owner, sells over $721m in shares
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- What Is an AI Research Agent?
- Bitcoin's 52% Crash Proves It's a Tech Stock: Here's What That Means for Portfolio Construction